Evidence map›Paper›PMID 33340337›Full record

ReviewApplied microbiology and biotechnology2021

Role and function of Chondrostereum purpureum in biocontrol of trees.

Leena Hamberg, Timo Saksa, Jarkko Hantula

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Comparative Efficacy ofPathogens (Basel, Switzerland) · 2022
    Article
  2. Silverleaf (Plants (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leena HambergNatural Resources Institute Finland, P.O. Box 2, (Latokartanonkaari 9), FI-00790, Helsinki, Finland. leena.hamberg@luke.fi.ORCID https://orcid.org/0000-0002-0009-7768
Timo SaksaNatural Resources Institute Finland, Juntintie 154, FI-77600, Suonenjoki, Finland.
Jarkko HantulaNatural Resources Institute Finland, P.O. Box 2, (Latokartanonkaari 9), FI-00790, Helsinki, Finland.

Funding

Natural Resources Institute Finland 41007-00096400Natural Resources Institute Finland 41007-00140900Natural Resources Institute Finland 41008-80000601
6 · The paper itself

Abstract

A decay fungus, Chondrostereum purpureum (Pers. Ex Fr.) Pouzar, has been investigated in Europe, Northern America and New Zealand for its ability to decay hardwood stumps and thus prevent sprouting. The aim of these investigations has been to find an alternative to mechanical (cutting only) and chemical sprout control (cutting and applying chemicals to stumps in order to prevent sprouting). Mechanical sprout control is not an efficient option due to hardwood tree species' ability to re-sprout efficiently after cutting, and therefore management costs are high. Chemicals would be efficient but due to their harmful effects on the environment, alternatives are needed. The fungal treatment, i.e., cutting accompanied with C. purpureum inoculum is an environmentally friendly and efficient option for sprout control. This mini-review comprises the role and function of C. purpureum in biocontrol of trees: the ecology of C. purpureum, its sprout control efficacy, factors affecting sprout control efficacy, devices in biological sprout control, potential risks, and the future perspectives of biological sprout control. KEY POINTS: • A fungus Chondrostereum purpureum is efficient in preventing sprouting of hardwoods • C. purpureum is not sensitive to environmental conditions • Devices should be developed for cost-efficient biological sprout control.

Indexed as

TreesAgaricalesEuropeNew ZealandNorth AmericaDecay fungusForestrySprout controlStump mortality

Identifiers

PMID33340337
PMCPMC7806553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.